Ahmad Daher, PhD, MD, MS

Performing highthroughput screening on glioma samples followed by pan-molecular profiling to establish drug/drug class-specific resistance and sensitivity markers. Molecular characterization of primary brain tumors in underserved minority groups. Characterization of circularing biomarkers in glioma patients. Growing brain tumor clinical trial portfolio.